In conclusion, high levels of preoperative insulin resistance or adiponectin are not associated with increased 30-day mortality, but a high level of adiponectin implies an increased 31-365-day mortality, and slightly prolonged length of intensive care unit and total hospital stay. Here, ADIPOQ is linked to Insulin resistance.